Skip to main content
Top
Published in: Quality of Life Research 4/2022

01-04-2022 | Macular Degeneration

Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life

Authors: Eva K. Fenwick, Ester P. X. Lee, Ryan E. K. Man, Kam Chun Ho, Raymond P. Najjar, Dan Milea, Kelvin Y. C. Teo, Anna C. S. Tan, Shu Yen Lee, Ian Yew San Yeo, Gavin S. W. Tan, Ranjana Mathur, Tien Yin Wong, Chui Ming Gemmy Cheung, Ecosse L. Lamoureux

Published in: Quality of Life Research | Issue 4/2022

Login to get access

Abstract

Purpose

We are developing an age-related macular degeneration (AMD) health-related quality of life (HRQoL) item bank, applicable to Western and Asian populations. We report primarily on content generation and refinement, but also compare the HRQoL issues reported in our study with Western studies and current AMD-HRQoL questionnaires.

Methods

In this cross-sectional, qualitative study of AMD patients attending the Singapore National Eye Centre (May–December 2019), items/domains were generated from: (1) AMD-specific questionnaires; (2) published articles; (3) focus groups/semi-structured interviews with AMD patients (n = 27); and (4) written feedback from retinal experts. Following thematic analysis, items were systematically refined to a minimally representative set and pre-tested using cognitive interviews with 16 AMD patients.

Results

Of the 27 patients (mean ± standard deviation age 67.9 ± 7.0; 59.2% male), 18 (66.7%), two (7.4%), and seven (25.9%) had no, early-intermediate, and late/advanced AMD (better eye), respectively. Whilst some HRQoL issues, e.g. activity limitation, mobility, lighting, and concerns were similarly reported by Western patients and covered by other questionnaires, others like anxiety about intravitreal injections, work tasks, and financial dependency were novel. Overall, 462 items within seven independent HRQoL domains were identified: Activity limitation, Lighting, Mobility, Emotional, Concerns, AMD management, and Work. Following item refinement, items were reduced to 219, with 31 items undergoing amendment.

Conclusion

Our 7-domain, 219-item AMD-specific HRQoL instrument will undergo psychometric testing and calibration for computerized adaptive testing. The future instrument will enable users to precisely, rapidly, and comprehensively quantify the HRQoL impact of AMD and associated treatments, with item coverage relevant across several populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012). Age-related macular degeneration. Lancet, 379(9827), 1728–1738.PubMedCrossRef Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012). Age-related macular degeneration. Lancet, 379(9827), 1728–1738.PubMedCrossRef
2.
go back to reference Wong, W. L., Su, X., Li, X., Cheung, C. M., Klein, R., Cheng, C. Y., & Wong, T. Y. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. The Lancet Global Health, 2(2), e106–e116.PubMedCrossRef Wong, W. L., Su, X., Li, X., Cheung, C. M., Klein, R., Cheng, C. Y., & Wong, T. Y. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. The Lancet Global Health, 2(2), e106–e116.PubMedCrossRef
3.
go back to reference Taylor, D. J., Hobby, A. E., Binns, A. M., & Crabb, D. P. (2016). How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open, 6(12), e011504.PubMedPubMedCentralCrossRef Taylor, D. J., Hobby, A. E., Binns, A. M., & Crabb, D. P. (2016). How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open, 6(12), e011504.PubMedPubMedCentralCrossRef
4.
go back to reference Bennion, A. E., Shaw, R. L., & Gibson, J. M. (2012). What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Social Science and Medicine, 75(6), 976–985.PubMedCrossRef Bennion, A. E., Shaw, R. L., & Gibson, J. M. (2012). What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Social Science and Medicine, 75(6), 976–985.PubMedCrossRef
5.
go back to reference Fenwick, E., Cheung, C., Ong, P., Tan, G., Lee, S., Yeo, I., Cheng, C.-Y., Wong, T., & Lamoureux, E. (2016). The impact of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy on vision-related quality of life in Asian patients. British Journal of Ophthalmology, 101(5), 591–596.CrossRef Fenwick, E., Cheung, C., Ong, P., Tan, G., Lee, S., Yeo, I., Cheng, C.-Y., Wong, T., & Lamoureux, E. (2016). The impact of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy on vision-related quality of life in Asian patients. British Journal of Ophthalmology, 101(5), 591–596.CrossRef
6.
go back to reference Boyle, J., Vukicevic, M., Koklanis, K., & Itsiopoulos, C. (2015). Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review. Psychology, Health & Medicine, 20(3), 296–310.CrossRef Boyle, J., Vukicevic, M., Koklanis, K., & Itsiopoulos, C. (2015). Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review. Psychology, Health & Medicine, 20(3), 296–310.CrossRef
7.
go back to reference Senra, H., Ali, Z., Balaskas, K., & Aslam, T. (2016). Psychological impact of anti-VEGF treatments for wet macular degeneration—A review. Graefes Archive for Clinical and Experimental Ophthalmology, 254(10), 1873–1880.CrossRef Senra, H., Ali, Z., Balaskas, K., & Aslam, T. (2016). Psychological impact of anti-VEGF treatments for wet macular degeneration—A review. Graefes Archive for Clinical and Experimental Ophthalmology, 254(10), 1873–1880.CrossRef
8.
go back to reference Baumhauer, J., & Bozic, K. (2016). Value-based healthcare: Patient-reported outcomes in clinical decision making. Clinical Orthopaedics and Related Research, 474, 1375–1378.PubMedPubMedCentralCrossRef Baumhauer, J., & Bozic, K. (2016). Value-based healthcare: Patient-reported outcomes in clinical decision making. Clinical Orthopaedics and Related Research, 474, 1375–1378.PubMedPubMedCentralCrossRef
9.
go back to reference Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMedCrossRef Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMedCrossRef
10.
go back to reference Khadka, J., McAlinden, C., & Pesudovs, K. (2012). Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Investigative Ophthalmology & Visual Science, 53(3), 1276.CrossRef Khadka, J., McAlinden, C., & Pesudovs, K. (2012). Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Investigative Ophthalmology & Visual Science, 53(3), 1276.CrossRef
11.
go back to reference Mitchell, J., Wolffsohn, J. S., Woodcock, A., Anderson, S. J., McMillan, C. V., Ffytche, T., Rubinstein, M., Amoaku, W., & Bradley, C. (2005). Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedPubMedCentralCrossRef Mitchell, J., Wolffsohn, J. S., Woodcock, A., Anderson, S. J., McMillan, C. V., Ffytche, T., Rubinstein, M., Amoaku, W., & Bradley, C. (2005). Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedPubMedCentralCrossRef
12.
go back to reference Mitchell, J., & Bradley, C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13(6), 1163–1175.PubMedCrossRef Mitchell, J., & Bradley, C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13(6), 1163–1175.PubMedCrossRef
13.
go back to reference Pondorfer, S. G., Terheyden, J. H., Overhoff, H., Stasch-Bouws, J., Holz, F. G., & Finger, R. P. (2021). Development of the vision impairment in low luminance questionnaire. Translational Vision Science & Technology, 10(1), 5–5.CrossRef Pondorfer, S. G., Terheyden, J. H., Overhoff, H., Stasch-Bouws, J., Holz, F. G., & Finger, R. P. (2021). Development of the vision impairment in low luminance questionnaire. Translational Vision Science & Technology, 10(1), 5–5.CrossRef
14.
go back to reference Kimel, M., Leidy, N. K., Tschosik, E., Dolan, C., Souied, E. H., Varma, R., & Bressler, N. M. (2016). Functional Reading Independence (FRI) Index: A new patient-reported outcome measure for patients with geographic atrophy. Investigative Ophthalmology & Visual Science, 57(14), 6298–6304.CrossRef Kimel, M., Leidy, N. K., Tschosik, E., Dolan, C., Souied, E. H., Varma, R., & Bressler, N. M. (2016). Functional Reading Independence (FRI) Index: A new patient-reported outcome measure for patients with geographic atrophy. Investigative Ophthalmology & Visual Science, 57(14), 6298–6304.CrossRef
15.
go back to reference Finger, R. P., Fenwick, E., Pesudovs, K., Marella, M., Lamoureux, E. L., & Holz, F. G. (2012). Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire. Ophthalmology, 119(11), 2351–2357.PubMedCrossRef Finger, R. P., Fenwick, E., Pesudovs, K., Marella, M., Lamoureux, E. L., & Holz, F. G. (2012). Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire. Ophthalmology, 119(11), 2351–2357.PubMedCrossRef
16.
go back to reference Cella, D., Gershon, R., Lai, J. S., & Choi, S. (2007). The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Quality of Life Research, 16(Suppl 1), 133–141.PubMedCrossRef Cella, D., Gershon, R., Lai, J. S., & Choi, S. (2007). The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Quality of Life Research, 16(Suppl 1), 133–141.PubMedCrossRef
17.
go back to reference Gibbons, R. D., Weiss, D. J., Kupfer, D. J., Frank, E., Fagiolini, A., Grochocinski, V. J., Bhaumik, D. K., Stover, A., Bock, R. D., & Immekus, J. C. (2008). Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatric Services (Washington, D. C.), 59(4), 361–368.CrossRef Gibbons, R. D., Weiss, D. J., Kupfer, D. J., Frank, E., Fagiolini, A., Grochocinski, V. J., Bhaumik, D. K., Stover, A., Bock, R. D., & Immekus, J. C. (2008). Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatric Services (Washington, D. C.), 59(4), 361–368.CrossRef
18.
go back to reference McCloud, C., Khadka, J., Gilhotra, J. S., & Pesudovs, K. (2014). Divergence in the lived experience of people with macular degeneration. Optometry and Vision Science, 91(8), 966–974.PubMedCrossRef McCloud, C., Khadka, J., Gilhotra, J. S., & Pesudovs, K. (2014). Divergence in the lived experience of people with macular degeneration. Optometry and Vision Science, 91(8), 966–974.PubMedCrossRef
19.
go back to reference Bian, W., Wan, J., Smith, G., Li, S., Tan, M., & Zhou, F. (2018). Domains of health-related quality of life in age-related macular degeneration: A qualitative study in the Chinese cultural context. BMJ Open, 8(4), e018756.PubMedPubMedCentralCrossRef Bian, W., Wan, J., Smith, G., Li, S., Tan, M., & Zhou, F. (2018). Domains of health-related quality of life in age-related macular degeneration: A qualitative study in the Chinese cultural context. BMJ Open, 8(4), e018756.PubMedPubMedCentralCrossRef
20.
go back to reference Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357.PubMedCrossRef Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357.PubMedCrossRef
21.
go back to reference Vaughn, S., Schumm, J., & Sinagub, J. (1996). Focus group interviews in education and psychology. Sage.CrossRef Vaughn, S., Schumm, J., & Sinagub, J. (1996). Focus group interviews in education and psychology. Sage.CrossRef
22.
go back to reference Wilkinson, S. (2004). Focus group research. In D. Silverman (Ed.), Qualitative research: Theory, method, practice (pp. 177–199). Sage. Wilkinson, S. (2004). Focus group research. In D. Silverman (Ed.), Qualitative research: Theory, method, practice (pp. 177–199). Sage.
23.
go back to reference Rice, P., & Ezzy, D. (1999). Qualitative research methods: A health focus. Oxford University Press. Rice, P., & Ezzy, D. (1999). Qualitative research methods: A health focus. Oxford University Press.
24.
go back to reference DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates—The PROMIS qualitative item review. Medical Care, 45(5), S12–S21.PubMedPubMedCentralCrossRef DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates—The PROMIS qualitative item review. Medical Care, 45(5), S12–S21.PubMedPubMedCentralCrossRef
25.
go back to reference Fenwick, E. K., Pesudovs, K., Khadka, J., Rees, G., Wong, T. Y., & Lamoureux, E. L. (2013). Evaluation of item candidates for a diabetic retinopathy quality of life item bank. Quality of Life Research, 22(7), 1851–1858.PubMedCrossRef Fenwick, E. K., Pesudovs, K., Khadka, J., Rees, G., Wong, T. Y., & Lamoureux, E. L. (2013). Evaluation of item candidates for a diabetic retinopathy quality of life item bank. Quality of Life Research, 22(7), 1851–1858.PubMedCrossRef
26.
go back to reference Khadka, J., Gothwal, V. K., McAlinden, C., Lamoureux, E. L., & Pesudovs, K. (2012). The importance of rating scales in measuring patient-reported outcomes. Health and Quality of Life, 10, 80–93.CrossRef Khadka, J., Gothwal, V. K., McAlinden, C., Lamoureux, E. L., & Pesudovs, K. (2012). The importance of rating scales in measuring patient-reported outcomes. Health and Quality of Life, 10, 80–93.CrossRef
28.
go back to reference Burton, A. E., Shaw, R. L., & Gibson, J. M. (2015). Living together with age-related macular degeneration: An interpretative phenomenological analysis of sense-making within a dyadic relationship. Journal of Health Psychology, 20(10), 1285–1295.PubMedCrossRef Burton, A. E., Shaw, R. L., & Gibson, J. M. (2015). Living together with age-related macular degeneration: An interpretative phenomenological analysis of sense-making within a dyadic relationship. Journal of Health Psychology, 20(10), 1285–1295.PubMedCrossRef
29.
go back to reference Lane, J., Rohan, E. M. F., Sabeti, F., Essex, R. W., Maddess, T., Dawel, A., Robbins, R. A., Barnes, N., He, X., & McKone, E. (2018). Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: A qualitative study and new community resources. PLoS One, 13(12), e0209218.PubMedPubMedCentralCrossRef Lane, J., Rohan, E. M. F., Sabeti, F., Essex, R. W., Maddess, T., Dawel, A., Robbins, R. A., Barnes, N., He, X., & McKone, E. (2018). Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: A qualitative study and new community resources. PLoS One, 13(12), e0209218.PubMedPubMedCentralCrossRef
30.
go back to reference McCloud, C., & Lake, S. (2015). Understanding the patient’s lived experience of neovascular age-related macular degeneration: A qualitative study. Eye (London, England), 29(12), 1561–1569.CrossRef McCloud, C., & Lake, S. (2015). Understanding the patient’s lived experience of neovascular age-related macular degeneration: A qualitative study. Eye (London, England), 29(12), 1561–1569.CrossRef
31.
go back to reference Senra, H., Balaskas, K., Mahmoodi, N., & Aslam, T. (2017). Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. American Journal of Ophthalmology, 177, 213–224.PubMedCrossRef Senra, H., Balaskas, K., Mahmoodi, N., & Aslam, T. (2017). Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. American Journal of Ophthalmology, 177, 213–224.PubMedCrossRef
32.
go back to reference Taylor, D. J., Edwards, L. A., Binns, A. M., & Crabb, D. P. (2018). Seeing it differently: Self-reported description of vision loss in dry age-related macular degeneration. Ophthalmic and Physiological Optics, 38(1), 98–105.PubMedCrossRef Taylor, D. J., Edwards, L. A., Binns, A. M., & Crabb, D. P. (2018). Seeing it differently: Self-reported description of vision loss in dry age-related macular degeneration. Ophthalmic and Physiological Optics, 38(1), 98–105.PubMedCrossRef
33.
go back to reference Henriksen, K., & Adhami, S. (2013). Patient experience of intravitreal injections in AMD. International Journal of Ophthalmic Practice, 1, 68–72.CrossRef Henriksen, K., & Adhami, S. (2013). Patient experience of intravitreal injections in AMD. International Journal of Ophthalmic Practice, 1, 68–72.CrossRef
34.
go back to reference Thetford, C., Hodge, S., Harding, S., Taylor, S., & Knox, P. (2013). Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections. The British Journal of Visual Impairment, 31(2), 89–101.CrossRef Thetford, C., Hodge, S., Harding, S., Taylor, S., & Knox, P. (2013). Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections. The British Journal of Visual Impairment, 31(2), 89–101.CrossRef
35.
go back to reference Sivaprasad, S., Tschosik, E. A., Guymer, R. H., Kapre, A., Suñer, I. J., Joussen, A. M., Lanzetta, P., & Ferrara, D. (2019). Living with geographic atrophy: An ethnographic study. Ophthalmology and Therapy, 8(1), 115–124.PubMedPubMedCentralCrossRef Sivaprasad, S., Tschosik, E. A., Guymer, R. H., Kapre, A., Suñer, I. J., Joussen, A. M., Lanzetta, P., & Ferrara, D. (2019). Living with geographic atrophy: An ethnographic study. Ophthalmology and Therapy, 8(1), 115–124.PubMedPubMedCentralCrossRef
36.
go back to reference Fenwick, E. K., Pesudovs, K., Khadka, J., Dirani, M., Rees, G., Wong, T. Y., & Lamoureux, E. L. (2012). The impact of diabetic retinopathy on quality of life: Qualitative findings from an item bank development project. Quality of Life Research, 21(10), 1771–1782.PubMedCrossRef Fenwick, E. K., Pesudovs, K., Khadka, J., Dirani, M., Rees, G., Wong, T. Y., & Lamoureux, E. L. (2012). The impact of diabetic retinopathy on quality of life: Qualitative findings from an item bank development project. Quality of Life Research, 21(10), 1771–1782.PubMedCrossRef
37.
go back to reference Khadka, J., McAlinden, C., Craig, J. E., Fenwick, E. K., Lamoureux, E. L., & Pesudovs, K. (2015). Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. Journal of Glaucoma, 24(1), 12–19.PubMedCrossRef Khadka, J., McAlinden, C., Craig, J. E., Fenwick, E. K., Lamoureux, E. L., & Pesudovs, K. (2015). Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. Journal of Glaucoma, 24(1), 12–19.PubMedCrossRef
39.
go back to reference Awang, H., Mansor, N., Nai Peng, T., & Nik Osman, N. A. (2018). Understanding ageing: Fear of chronic diseases later in life. Journal of International Medical Research, 46(1), 175–184.CrossRef Awang, H., Mansor, N., Nai Peng, T., & Nik Osman, N. A. (2018). Understanding ageing: Fear of chronic diseases later in life. Journal of International Medical Research, 46(1), 175–184.CrossRef
40.
go back to reference Lee, M. C., Hinderer, K. A., & Alexander, C. S. (2018). What matters most at the end-of-life for Chinese Americans? Gerontology and Geriatric Medicine, 4, 2333721418778195.PubMedPubMedCentralCrossRef Lee, M. C., Hinderer, K. A., & Alexander, C. S. (2018). What matters most at the end-of-life for Chinese Americans? Gerontology and Geriatric Medicine, 4, 2333721418778195.PubMedPubMedCentralCrossRef
41.
go back to reference Bedford, O., & Yeh, K. H. (2019). The history and the future of the psychology of filial piety: Chinese norms to contextualized personality construct. Frontiers in Psychology, 10, 100.PubMedPubMedCentralCrossRef Bedford, O., & Yeh, K. H. (2019). The history and the future of the psychology of filial piety: Chinese norms to contextualized personality construct. Frontiers in Psychology, 10, 100.PubMedPubMedCentralCrossRef
42.
go back to reference Wu, Z., Ayton, L. N., Luu, C. D., & Guymer, R. H. (2015). Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. JAMA Ophthalmology, 133(4), 442–448.PubMedCrossRef Wu, Z., Ayton, L. N., Luu, C. D., & Guymer, R. H. (2015). Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. JAMA Ophthalmology, 133(4), 442–448.PubMedCrossRef
43.
go back to reference Fenwick, E. K., Barnard, J., Gan, A., Loe, B. S., Khadka, J., Pesudovs, K., et al. (2020). Computerized adaptive tests: Efficient and precise assessment of the patient-centered impact of diabetic retinopathy. Translational Vision Science & Technology, 9(7), 3. https://doi.org/10.1167/tvst.9.7.3.CrossRef Fenwick, E. K., Barnard, J., Gan, A., Loe, B. S., Khadka, J., Pesudovs, K., et al. (2020). Computerized adaptive tests: Efficient and precise assessment of the patient-centered impact of diabetic retinopathy. Translational Vision Science & Technology, 9(7), 3. https://​doi.​org/​10.​1167/​tvst.​9.​7.​3.CrossRef
44.
go back to reference Haley, S. M., Ni, P., Jette, A. M., Tao, W., Moed, R., Meyers, D., & Ludlow, L. H. (2009). Replenishing a computerized adaptive test of patient-reported daily activity functioning. Quality of Life Research, 18(4), 461–471.PubMedPubMedCentralCrossRef Haley, S. M., Ni, P., Jette, A. M., Tao, W., Moed, R., Meyers, D., & Ludlow, L. H. (2009). Replenishing a computerized adaptive test of patient-reported daily activity functioning. Quality of Life Research, 18(4), 461–471.PubMedPubMedCentralCrossRef
Metadata
Title
Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life
Authors
Eva K. Fenwick
Ester P. X. Lee
Ryan E. K. Man
Kam Chun Ho
Raymond P. Najjar
Dan Milea
Kelvin Y. C. Teo
Anna C. S. Tan
Shu Yen Lee
Ian Yew San Yeo
Gavin S. W. Tan
Ranjana Mathur
Tien Yin Wong
Chui Ming Gemmy Cheung
Ecosse L. Lamoureux
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 4/2022
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02989-w

Other articles of this Issue 4/2022

Quality of Life Research 4/2022 Go to the issue